Clinical trial
Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head…
NCT00003264 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003264 |
|---|---|
| Title | Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer |
| Official title | Phase II Evaluation of Weekly Cisplatin and Gemcitabine in the Treatment of Advanced (Recurrent or Metastatic) Carcinoma of the Head and Neck |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine hydrochloride |
| Enrollment | 22 |
| Start date | Oct 1, 1997 |
| Primary completion | Feb 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Mar 1, 2004 |
| Last update posted | Apr 17, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: